Posted in | News | Energy

Alcan Recognized for Transparency in Addressing Global Climate Change

Alcan Inc. announced today that it has been selected to the Climate Disclosure Leadership Index in recognition of its transparency and its work in addressing global climate change. Comprised of 68 Financial Times 500 companies, the Index is part of a Carbon Disclosure Project report that outlines the key features that make climate change a critical shareholder value issue for both investors and global corporations.

"Alcan recognizes that climate change is an issue that has an impact on the long-term sustainability of our business," said Dick Evans, President and CEO, Alcan Inc. "Being listed on the Climate Disclosure Leadership Index recognizes Alcan's ongoing commitment to addressing the issue of climate change by reducing greenhouse gas emissions (GHGs) through leading-edge technology and clean, renewable energy solutions," he added.

The principal vehicle for Alcan's commitment to addressing climate change is the Company's GHG emissions reduction program, TARGET, which was implemented in 2001 and is a key component of its Environment, Health and Safety (EHS FIRST) management system. Alcan began to systematically monitor and measure its air emissions in 1990, and has since then significantly reduced its specific perfluorocarbon (PFCs - a greenhouse gas) emissions by 80 percent. Alcan has also committed to an additional 10% reduction in the intensity of direct greenhouse gas emissions by 2010.

Alcan has also proactively addressed the challenges of climate change in the public discourse by participating in organizations like the United States Climate Action Partnership and by recently signing the UN Global Compact's "Caring for Climate: The Business Leadership Platform" statement.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.